Projects funded by the NCN
Testing of cation carrier derivatives as prospective therapeutic agents for the treatment of B-cell-derived malignancies.
2019/35/B/NZ5/01445
Keywords:
CD20 cation carrier salinomycin rituximab
Descriptors:
- NZ5_7: Human disease treatment
- NZ6_1: Adaptive and innate immunity
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Warszawski Uniwersytet Medyczny, Wydział Lekarski
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 18 - announced on 2019-09-16
Amount awarded: 2 345 246 PLN
Project start date (Y-m-d): 2020-07-06
Project end date (Y-m-d): 2024-07-05
Project duration:: 48 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.